Brazil’s securities regulator, the CVM, ruled that US-based asset manager Centaurus Capital LP must make a tender offer for shares of Oncoclinicas do Brasil Servicos Medicos SA, according to Bloomberg.
The decision overturned the regulator’s technical staff and escalated a long-running dispute among some of the cancer-care provider’s biggest shareholders.